The Journal of Behavioral Health Services & Research

, 36:267

Longitudinal Effects of LAAM and Methadone Maintenance on Heroin Addict Behavior

  • M. Douglas Anglin
  • Bradley T. Conner
  • Jeffrey J. Annon
  • Douglas Longshore
Special Issue

DOI: 10.1007/s11414-008-9155-x

Cite this article as:
Anglin, M.D., Conner, B.T., Annon, J.J. et al. J Behav Health Serv Res (2009) 36: 267. doi:10.1007/s11414-008-9155-x

Abstract

Levo-alpha-acetylmethadol maintenance (LAAM) was compared to methadone maintenance (MM) on the behavioral performance of 315 heroin addicts before, during, and after 12 months of fully subsidized treatment. Assessments of drug use, criminal behavior, HIV risk behaviors, and employment and residential status were obtained at treatment intake and at 6, 12, and 18 months after admission. Treatment retention and in-treatment suppression of heroin use were significantly better for the LAAM group than for the MM group. Improvements were also noted during treatment in criminal behavior, criminal justice involvement, and employment status, and there were reductions in injection HIV risk and number of sexual partners. Most significant effects were primarily related to active participation in maintenance treatment. Under subsidized treatment, retention rates were two to four times that of similar clients in local community programs during the same period. LAAM was a useful and a potentially important addition to treatment options for opiate addiction, conferring greater retention and opiate suppression benefits. Its removal from application provides a historical lesson concerning the introduction of new medications into addiction health services.

Keywords

treatment retentiondrug treatment outcomesrisk reductionmaintenance medication policydrug abuse treatment funding

Copyright information

© National Council for Community Behavioral Healthcare 2008

Authors and Affiliations

  • M. Douglas Anglin
    • 1
  • Bradley T. Conner
    • 1
  • Jeffrey J. Annon
    • 1
  • Douglas Longshore
    • 1
  1. 1.Integrated Substance Abuse Programs, Semel Institute for Neuroscience and Human BehaviorDavid Geffen School of Medicine, UCLALos AngelesUSA